Global Anti-Infective Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-01-25
- Report ID: 44219
- Pages: 110
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Marketss analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Anti-Infective Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Anti-Infective Drug Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Anti-Infective Drug Market
Gilead Sciences
GlaxoSmithKline
Merck
Teva Pharmaceutical Industries
Johnson & Johnson
Boehringer Ingelheim
Pfizer
Mylan N.V.
Bristol-Myers Squibb
F. Hoffmann-La Roche
Shanghai Pharmaceuticals
...
Major Type of Anti-Infective Drug Covered in Prudent Markets report:
Antibiotics
Antivirals
Antifungals
Others
Application Segments Covered in Prudent Markets Market
minor infections
complex surgery
immuno-suppressive treatments
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Anti-Infective Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Antibiotics -Product Introduction and Major Manufacturers
1.1.2 Antivirals -Product Introduction and Major Manufacturers
1.1.3 Antifungals -Product Introduction and Major Manufacturers
1.1.4 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Anti-Infective Drug Status and Prospect (2015-2026)
2.1.1 China Anti-Infective Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Anti-Infective Drug Status and Prospect (2015-2026)
2.2.1 EU Anti-Infective Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Anti-Infective Drug Status and Prospect (2015-2026)
2.3.1 USA Anti-Infective Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Anti-Infective Drug Status and Prospect (2015-2026)
2.4.1 Japan Anti-Infective Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Anti-Infective Drug Status and Prospect (2015-2026)
2.5.1 India Anti-Infective Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Anti-Infective Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Anti-Infective Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Anti-Infective Drug Status and Prospect (2015-2026)
2.7.1 South America Anti-Infective Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Anti-Infective Drug Status and Prospect (2015-2026)
2.8.1 Anti-Infective Drug Market Size and Growth Rate (2015-2026)
2.8.2 Anti-Infective Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Anti-Infective Drug Market Assessment by Segment
3.1 Global Anti-Infective Drug Capacity and Growth Rate
3.2 Global Anti-Infective Drug Sales by Type
3.3 Global Anti-Infective Drug Sales Revenue by Type
3.4 Global Anti-Infective Drug Consumption by Application
4 Global Anti-Infective Drug Market Assessment by Regions
4.1 Global Anti-Infective Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Anti-Infective Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Anti-Infective Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Anti-Infective Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Anti-Infective Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Anti-Infective Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Anti-Infective Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Anti-Infective Drug Sales Revenue Market Share of Manufacturers (2019-2020)
7 Anti-Infective Drug Competitive Analysis
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Profiles
7.1.2 Gilead Sciences Product Introduction
7.1.3 Gilead Sciences Anti-Infective Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Profiles
7.2.2 GlaxoSmithKline Product Introduction
7.2.3 GlaxoSmithKline Anti-Infective Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Merck
7.3.1 Merck Company Profiles
7.3.2 Merck Product Introduction
7.3.3 Merck Anti-Infective Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Teva Pharmaceutical Industries
7.4.1 Teva Pharmaceutical Industries Company Profiles
7.4.2 Teva Pharmaceutical Industries Product Introduction
7.4.3 Teva Pharmaceutical Industries Anti-Infective Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Profiles
7.5.2 Johnson & Johnson Product Introduction
7.5.3 Johnson & Johnson Anti-Infective Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Profiles
7.6.2 Boehringer Ingelheim Product Introduction
7.6.3 Boehringer Ingelheim Anti-Infective Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Pfizer
7.7.1 Pfizer Company Profiles
7.7.2 Pfizer Product Introduction
7.7.3 Pfizer Anti-Infective Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Mylan N.V.
7.8.1 Mylan N.V. Company Profiles
7.8.2 Mylan N.V. Product Introduction
7.8.3 Mylan N.V. Anti-Infective Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Profiles
7.9.2 Bristol-Myers Squibb Product Introduction
7.9.3 Bristol-Myers Squibb Anti-Infective Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Company Profiles
7.10.2 F. Hoffmann-La Roche Product Introduction
7.10.3 F. Hoffmann-La Roche Anti-Infective Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Shanghai Pharmaceuticals
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
